NextGen Precision Health Building, Clinical and Translational Science Unit is a clinical research site located in Columbia, Missouri, United States 65211.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
NextGen Precision Health Building, Clinical and Translational Science Unit has participated in 3 clinical trials with 3 currently active.
Therapeutic areas: Generalized Myasthenia Gravis, Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis.
Sponsors: University of Missouri-Columbia.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NextGen Precision Health Building, Clinical and Translational Science Unit has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NextGen Precision Health Building, Clinical and Translational Science Unit has 3 clinical trials on record, with 3 currently active. Their work covers Generalized Myasthenia Gravis, Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis.
NextGen Precision Health Building, Clinical and Translational Science Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.